Synaptophysin expression in mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis-Reference-Cited by-同舟云学术

Synaptophysin expression in mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis

Published:2021-03 Issue: Volume:146 Page:145-154
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Fassan Matteo^ORCID,Milione Massimo,Maddalena Giulia^ORCID,Cremolini Chiara,Schirripa Marta,Pietrantonio Filippo,Pella Nicoletta,Dell’Aquila Emanuela,Sperti Elisa,Zichi Clizia^ORCID,Bergamo Francesca,Volante Marco,Boccaccino Alessandra,Morano Federica,Cortiula Francesco^ORCID,De Maglio Giovanna,Rimassa Lorenza^ORCID,Smiroldo Valeria,Calvetti Lorenzo,Aprile Giuseppe,Salvatore Lisa^ORCID,Santini Daniele,Salmaso Roberta,Centonze Giovanni,Biason Paola^ORCID,Borga Chiara,Lonardi Sara^ORCID,Zagonel Vittorina,Dei Tos Angelo P.,Di Maio Massimo,Loupakis Fotios

Funder

Regione del Veneto

Ministero della Salute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. The heterogeneous clinical and pathological landscapes of metastatic Braf-mutated colorectal cancer;Fanelli;Cancer Cell Int,2020

2. Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trials;Seligmann;Ann Oncol,2017

3. A validated prognostic classifier for (V600E)BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study;Loupakis;Eur J Cancer,2019

4. Evolving strategies for the management of BRAF-mutant metastatic colorectal cancer;Lee;Oncology,2019

5. Class 1, 2, and 3 BRAF-mutated metastatic colorectal cancer: a detailed clinical, pathologic, and molecular characterization;Schirripa;Clin Cancer Res,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathological Evaluation and Classification of Digestive Neuroendocrine Neoplasms;Neuroendocrine Tumours;2024

2. High expression of insulinoma‐associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin;The Journal of Pathology: Clinical Research;2023-08-22

3. Identification of immune-related molecular markers in intracranial aneurysm (IA) based on machine learning and cytoscape-cytohubba plug-in;BMC Genomic Data;2023-04-11

4. European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma;Journal of Neuroendocrinology;2023-03

5. BRAF-mutated colorectal adenocarcinomas: Pathological heterogeneity and clinical implications;Critical Reviews in Oncology/Hematology;2022-04